We are live on
!
Find out more
JC
Jacobs & Co Portfolio holdings
AUM
$1.17B
1-Year Est. Return
37.3%
This Fund
S&P 500
This Quarter
Est. Return
+4.22%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$532M
AUM Growth
+$24M
(+4.7%)
Cap. Flow
+$3.61M
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
22.6%
Holding
125
New
2
Increased
45
Reduced
57
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newell Brands
NWL
|
+$904K |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$537K |
| 3 |
DuPont de Nemours
DD
|
+$447K |
| 4 |
Procter & Gamble
PG
|
+$439K |
| 5 |
AB InBev
BUD
|
+$402K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$1.16M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$427K |
| 3 |
Boeing
BA
|
+$291K |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$229K |
| 5 |
McDonald's
MCD
|
+$186K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.51% |
| 2 | Technology | 15.73% |
| 3 | Industrials | 12.88% |
| 4 | Communication Services | 12.52% |
| 5 | Consumer Staples | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Novartis
NVS
$297B
| $298K | 0.06% |
3,878
-558
| -13% | -$42.1K |
|
|
TWTR
102
DELISTED
Twitter, Inc.
TWTR
| $280K | 0.05% |
16,645
-8,822
| -35% | -$154K |
|
|
GAM
103
General American Investors Company
GAM
$1.56B
| $270K | 0.05% |
7,516
-1,300
| -15% | -$45.4K |
|
104
Johnson & Johnson
JNJ
$618B
| $269K | 0.05% |
2,821
| – | – |
|
105
Lowe's Companies
LOW
$117B
| $264K | 0.05% |
3,305
| – | – |
|
106
Hewlett Packard
HPE
$63.4B
| $263K | 0.05% |
17,900
-5,302
| -23% | -$72.3K |
|
|
MON
107
DELISTED
Monsanto Co
MON
| $257K | 0.05% |
2,152
-310
| -13% | -$36.5K |
|
108
Conagra Brands
CAG
$6.94B
| $256K | 0.05% |
7,600
| – | – |
|
109
Huntington Bancshares
HBAN
$34.4B
| $256K | 0.05% |
18,400
| – | – |
|
110
Masco
MAS
$14.1B
| $252K | 0.05% |
6,475
| – | – |
|
111
Snap-on
SNA
$21.2B
| $249K | 0.05% |
4,104
| – | – |
|
112
Autodesk
ADSK
$49.5B
| $246K | 0.05% |
2,192
| – | – |
|
113
Lockheed Martin
LMT
$134B
| $232K | 0.04% |
+748
| New | +$223K |
|
114
JPMorgan Chase
JPM
$935B
| $230K | 0.04% |
4,890
-450
| -8% | -$41.5K |
|
115
Texas Instruments
TXN
$252B
| $211K | 0.04% |
+2,356
| New | +$194K |
|
116
MetLife
MET
$61.9B
| $201K | 0.04% |
3,880
-1,147
| -23% | -$55.9K |
|
|
DD
117
DELISTED
Du Pont De Nemours E I
DD
| – | – |
-5,300
| Closed | -$427K |
|
|
WFM
118
DELISTED
Whole Foods Market Inc
WFM
| – | – |
-5,444
| Closed | -$229K |
|
Similar funds
OCAI
BONST
AMI
GAB
SCP
FG
FP
AC
Jacobs & Co's Q3 2017 Portfolio in Review
As of Q3 2017, Jacobs & Co held 125 positions worth $532M, up 4.7% from $508M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 3.2%. Jacobs & Co opened 2 new positions and exited 2, leaving the 125-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.
- Jacobs & Co's largest Q3 2017 buy was Lockheed Martin: 748 shares worth $232K.
- Jacobs & Co added most to Newell Brands in Q3 2017, an estimated $904K increase.
- Jacobs & Co's biggest Q3 2017 reduction was Regeneron Pharmaceuticals, cutting an estimated $1.16M.
- Jacobs & Co fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $427K.
- Jacobs & Co's ten largest holdings make up 23% of its $532M portfolio in Q3 2017.
- Jacobs & Co opened 2 new positions and closed 2 in Q3 2017.
- Jacobs & Co's portfolio value rose 4.7% quarter-over-quarter to $532M.
Based on Jacobs & Co's 13F filing for Q3 2017, filed 14 Nov 2017.